Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and promoter methylation in cervical oncogenic lesions and cancer.

J Cell Mol Med · 2013 · PMC3822654 · PMID 23444906

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Using Kruskal–Wallis for MTHFR promoter methylation we noted highly significant differences in median data between different cytological groups ( Table 3 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.